To further investigate the therapeutic effects of sEV, we administered Sbno1-NSCs-sEV, GFP-NSCs-sEV, or PBS (control) via stereotactic intracerebral injection to mice after stroke. This evidence concerns the gene SBNO1 and stroke disorder.